Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 184 publications
Long-term prognosis of patients surviving progressive multifocal leukoencephalopathy.
Journal: Brain : a journal of neurology
Published: December 30, 2025
Towards pharmacological prevention of Alzheimer disease.
Journal: Nature reviews. Neurology
Published: September 18, 2025
Treating Alzheimer's disease in a person living with HIV.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: September 12, 2025
A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial.
Journal: Neurology open access
Published: July 08, 2025
ENLITE PD: A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: June 15, 2025
Interpreting the evidence on gantenerumab for dominantly inherited Alzheimer's disease - Authors' reply.
Journal: The Lancet. Neurology
Published: June 13, 2025
A Multi-Center Retrospective Cohort Study of Neurosarcoidosis Myelitis: Current Observations and Future Directions.
Journal: Annals of clinical and translational neurology
Published: May 23, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial.
Journal: medRxiv : the preprint server for health sciences
Published: February 20, 2025
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 12, 2025
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: December 19, 2024
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial.
Journal: The Lancet. Neurology
Published: September 05, 2024
Last Updated: 09/26/2026